Amarin Corporation PLC reports results for the quarter ended in September 30 - Earnings Summary

• Amarin Corporation PLC AMRN.OQ reported a quarterly adjusted loss of 6 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of three analysts for the quarter was for a loss of 5 cents per share.

• Revenue fell 36.6% to $41.85 million from a year ago; analysts expected $44.51 million.

• Amarin Corporation PLC's reported EPS for the quarter was a loss of 6 cents​.

• The company reported a quarterly loss of $25.13 million.

• Amarin Corporation PLC shares had fallen by 2.4% this quarter and lost 29.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 9.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 2 "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "sell"

Wall Street's median 12-month price target for Amarin Corporation PLC is $1.00

This summary was machine generated from LSEG data October 31 at 02:37 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)